Mirzaei S, Yazdi-Feyzabadi V, Mehrolhassani M, Nakhaee N, Oroomiei N
Addict Sci Clin Pract. 2024; 19(1):80.
PMID: 39533357
PMC: 11555793.
DOI: 10.1186/s13722-024-00511-4.
Carter E, Rine N, Kistamgari S, Hays H, Spiller H, Yang J
Inj Epidemiol. 2024; 11(1):59.
PMID: 39487483
PMC: 11529557.
DOI: 10.1186/s40621-024-00547-9.
Pryce K, Serafini R, Ramakrishnan A, Nicolais A, Giosan I, Polizu C
Nat Neurosci. 2023; 26(7):1229-1244.
PMID: 37291337
PMC: 10752505.
DOI: 10.1038/s41593-023-01350-3.
Carpenter K, Altman R
Biomolecules. 2023; 13(2).
PMID: 36830756
PMC: 9953178.
DOI: 10.3390/biom13020387.
Du Z, Jiang Y, Lu R, Shen Y, Ou M, Wang Z
Front Psychiatry. 2023; 13:1082538.
PMID: 36699480
PMC: 9868594.
DOI: 10.3389/fpsyt.2022.1082538.
Pharmacovigilance Signals of the Opioid Epidemic over 10 Years: Data Mining Methods in the Analysis of Pharmacovigilance Datasets Collecting Adverse Drug Reactions (ADRs) Reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System....
Chiappini S, Vickers-Smith R, Guirguis A, Corkery J, Martinotti G, Harris D
Pharmaceuticals (Basel). 2022; 15(6).
PMID: 35745593
PMC: 9231103.
DOI: 10.3390/ph15060675.
Using a multi-module web-app to prevent substance use among students at a Hispanic Serving Institution: development and evaluation design.
Rainisch B, Dahlman L, Vigil J, Forster M
BMC Public Health. 2022; 22(1):1198.
PMID: 35705975
PMC: 9202112.
DOI: 10.1186/s12889-022-13428-x.
Increase of high-risk tramadol use and harmful consequences in France from 2013 to 2018: Evidence from the triangulation of addictovigilance data.
Roussin A, Soeiro T, Fouque C, Jouanjus E, Frauger E, Fouilhe N
Br J Clin Pharmacol. 2022; 88(8):3789-3802.
PMID: 35318713
PMC: 9545570.
DOI: 10.1111/bcp.15323.
Chronic Pain in the Elderly: Mechanisms and Perspectives.
Dagnino A, Campos M
Front Hum Neurosci. 2022; 16:736688.
PMID: 35308613
PMC: 8928105.
DOI: 10.3389/fnhum.2022.736688.
Setting the policy agenda for the treatment of substance use disorders in Iran.
Mirzaei S, Yazdi-Feyzabadi V, Mehrolhassani M, Nakhaee N, Oroomiei N
Harm Reduct J. 2022; 19(1):27.
PMID: 35292060
PMC: 8922872.
DOI: 10.1186/s12954-022-00612-w.
Association of State-Imposed Restrictions on Gabapentin with Changes in Prescribing in Medicare.
Grauer J, Cramer J
J Gen Intern Med. 2022; 37(14):3630-3637.
PMID: 35018568
PMC: 9585149.
DOI: 10.1007/s11606-021-07314-2.
Kinetics and Mechanism of Fentanyl Dissociation from the μ-Opioid Receptor.
Mahinthichaichan P, Vo Q, Ellis C, Shen J
JACS Au. 2022; 1(12):2208-2215.
PMID: 34977892
PMC: 8715493.
DOI: 10.1021/jacsau.1c00341.
Early Detection of Prescription Drug Abuse Using Doctor Shopping Monitoring From Claims Databases: Illustration From the Experience of the French Addictovigilance Network.
Soeiro T, Lacroix C, Pradel V, Lapeyre-Mestre M, Micallef J
Front Psychiatry. 2021; 12:640120.
PMID: 34079478
PMC: 8165176.
DOI: 10.3389/fpsyt.2021.640120.
Beyond the 'purple drank': Study of promethazine abuse according to the European Medicines Agency adverse drug reaction reports.
Chiappini S, Schifano F, Corkery J, Guirguis A
J Psychopharmacol. 2021; 35(6):681-692.
PMID: 33427017
PMC: 8278560.
DOI: 10.1177/0269881120959615.
Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations.
Tanna R, Tian D, Cech N, Oberlies N, Rettie A, Thummel K
J Pharmacol Exp Ther. 2020; 376(1):64-73.
PMID: 33093187
PMC: 7745086.
DOI: 10.1124/jpet.120.000270.
What about "Pharming"? Issues Regarding the Misuse of Prescription and Over-the-Counter Drugs.
Chiappini S, Schifano F
Brain Sci. 2020; 10(10).
PMID: 33066476
PMC: 7602178.
DOI: 10.3390/brainsci10100736.
Carfentanil Outbreak - Florida, 2016-2017.
Delcher C, Wang Y, Vega R, Halpin J, Gladden R, ODonnell J
MMWR Morb Mortal Wkly Rep. 2020; 69(5):125-129.
PMID: 32027630
PMC: 7004395.
DOI: 10.15585/mmwr.mm6905a2.
Prescribed and non-prescribed gabapentin use among persons seeking inpatient opioid detoxification.
Stein M, Kenney S, Anderson B, Conti M, Bailey G
J Subst Abuse Treat. 2020; 110:37-41.
PMID: 31952626
PMC: 6981248.
DOI: 10.1016/j.jsat.2019.12.007.
Long-term use of hydrocodone vs. oxycodone in primary care.
Harris R, Kranzler H, Chang K, Doubeni C, Gross R
Drug Alcohol Depend. 2019; 205:107524.
PMID: 31707268
PMC: 9338763.
DOI: 10.1016/j.drugalcdep.2019.06.026.
Trends in prior receipt of prescription opioid or adjuvant analgesics among patients with incident opioid use disorder or opioid-related overdose from 2006 to 2016.
Wei Y, Chen C, Schmidt S, LoCiganic W, Winterstein A
Drug Alcohol Depend. 2019; 204:107600.
PMID: 31586806
PMC: 6927577.
DOI: 10.1016/j.drugalcdep.2019.107600.
